
News|Articles|October 1, 2008
FDA Pipeline preview, October 2008 (vernakalant, doripenem, custirsen, droxidopa, amrubicin, dronedarone, imatinib)
Recent FDA action (through October 2008) related to vernakalant, doripenem, custirsen, droxidopa, amrubicin, dronedarone, and imatinib.
Advertisement
Approvable designation*
Complete responses*
Fast-track designations
Orphan drug designations
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Transparency paves the way for lower costs and equitable access
2
New self-injectable biologics promise cost savings and patient convenience
3
World AIDS Day: 10 things to know about AIDS in 2025
4
Evaluating Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease: Written Recap
5






















































